ICD therapy in Brugada syndrome is associated with high complication rates, requiring careful individualized programming and management to ensure safety.
Supports cautious ICD use in Brugada syndrome; leaves open optimal device strategies for prospective trials.
Our review highlights the difficulties we face when treating patients with Brugada syndrome (BS) by an implantable cardioverter defibrillator (ICD). Higher defibrillation thresholds, high inappropriate shock rates because of sinus tachycardia and supraventricular tachycardias, T wave oversensing, and high lead failure rates should be expected. Psychosocial adjustment problems also occur frequently in this patient population. These high complications rates are because of specific characteristics of the BS patient population, consisting of young, active patients with a primary electrical disease. The management strategies include prevention and early recognition of the expected complications. Additionally, individualized careful programming of the ICD is essential to ensure maximal safety and minimal complication rates in patients with BS.
No takes yet. Share an insight, caveat, or question.
Sarkozy et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: